Patents by Inventor Marc Joris De Brabander

Marc Joris De Brabander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5955485
    Abstract: The present invention is concerned with the method of using a 2,3-dihydro-imidazo?2,1-b!benzothiazole derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from ageing of, or degenerative diseases of the nervous and vascular system which are associated with oxidative stress.
    Type: Grant
    Filed: August 12, 1997
    Date of Patent: September 21, 1999
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Marc Joris De Brabander, Anne Simone Josephine Lesage, Josepha Eduarda Maria Francisca Leysen
  • Patent number: 5872013
    Abstract: An aggregate for qualitatively or quantitatively determining bindable substances. Said aggregate comprises an ultra small colloidal particle and a specific binding agent characterized in that the mean diameter of the colloidal particle is below 2 nm. Preferably the size of the metal particle is selected so that the aggregate is capable of penetrating in standard biological specimens. The invention further provides a universally applicable detection system for determining bindable substances in particular in living material. Further there is provided a process for preparing said aggregate.
    Type: Grant
    Filed: October 4, 1995
    Date of Patent: February 16, 1999
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Johannes Leonardus Maria Leunissen, Marc Joris De Brabander, Petrus Franciscus Elisabeth Maria Van de Plas